Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Launches Minastrin Generic In The United States

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has unveiled the authorized generic version of Minastrin, an oral contraceptive that is c.....»»

Category: topSource: insidermonkeyMar 20th, 2017

Drugmaker Teva hires new CEO to restore its health

Teva Pharmaceutical Industries Ltd names H Lundbeck A/S Chief Executive Kare Schultz as its new CEO and president, as it struggles with heavy debts and fierce competition for its generic drugs in the United States. Amy Pollock reports.....»»

Category: videoSource: reutersSep 11th, 2017

Teva Submits BLA to FDA for Migraine Candidate Fremanezumab

Teva Pharma (TEVA) submits BLA seeking approval for its pipeline candidate, Fremanezumab, as a preventive treatment for migraine in the United States. Teva Pharmaceutical Industries.....»»

Category: worldSource: nytOct 19th, 2017

Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka

Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a generic version of Valeant Pharmaceuticals International, Inc.'s (VRX) diabetes drug, Glumetza, in the U.S. Teva .....»»

Category: topSource: zacksMay 16th, 2017

Teva Launches Authorized Generic of Allergan"s Minastrin

Teva Pharmaceutical I.....»»

Category: topSource: zacksMar 17th, 2017

Teva"s stock drops after J.P. Morgan downgrades to rare bearish rating

Shares of Teva Pharmaceutical Industries Ltd. shed 2.2% in premarket trade Monday, after the generic drug maker was downgraded at J.P. Morgan to a rare bearish rating, citing concerns ove.....»»

Category: topSource: marketwatchNov 13th, 2017

Teva"s stock, bonds fall after credit rating slashed to junk at Fitch

Shares of Teva Pharmaceutical Industries Ltd. sank 3.6% in premarket trade Tuesday, after the Israel-based generic drug maker's credit rating was cut by two notches into "junk" territory by Fitch Ratings. Teva's most active bonds, the 3.....»»

Category: topSource: marketwatchNov 7th, 2017

Generic drugmakers, distributor shares slide after Teva reports worse pricing environment

Generic drugmakers and drug distributors' shares sunk in Thursday trade after Teva Pharmaceutical Industries Ltd. reported worse price erosion for generic drugs in the latest quarter and lowered its 2017 guidance. Teva.....»»

Category: topSource: marketwatchNov 2nd, 2017

Shares of large generic drugmakers fall

Shares of several large generic drugmakers fell in Wednesday midday trade. Mylan NV shares dropped 2.7%, Teva Pharmaceutical Industries Ltd. shares dropped 2.1% , Taro Pharmaceutical Industries .....»»

Category: topSource: marketwatchOct 18th, 2017

Thursday’s Vital Data: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Netflix, Inc. (NFLX) and JPMorgan Chase & Co. (JPM)

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Teva (TEVA) options surge on Mylan N.V.’s generic .....»»

Category: topSource: investorplaceOct 5th, 2017

Mylan"s Generic Copaxone Arrives, Teva Sales To Take A Hit

The FDA dealt yet another blow to struggling Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) investors by approving rival Mylan N.V. (NASDAQ: MYL)’s generic version of Teva’s Copaxone multiple sclerosis drug. Latest Ratings .....»»

Category: blogSource: benzingaOct 4th, 2017

Mylan jumps 15% premarket after FDA OK for MS drug

Shares in Mylan NV rose 15% in premarket action after the maker of generic drugs late Tuesday announced that the Food and Drug Administration had approved its generic versions for Teva Pharmaceutical Industries Ltd.'s Copaxo.....»»

Category: topSource: marketwatchOct 4th, 2017

Teva shares surge 2.2% after Mylan says it will delay generic Copaxone launch to 2018

Teva Pharmaceutical Industries Ltd. shares surged 2.2% in premarket trade Wednesday after Mylan NV said it plans to defer its generic Copaxon.....»»

Category: topSource: marketwatchAug 9th, 2017

Indian pharma poised for US acquisitions

Mumbai, 7 AugustThe assets of Teva Pharmaceutical Industries have become acquisition targets following devastating results announced last week by the world's biggest maker of generic medicines.Teva's profits in the second quarter dr.....»»

Category: topSource: business-standardAug 7th, 2017

Teva"s stock keeps plunging on heavy volume after Morgan Stanley downgrade

Shares of Teva Pharmaceutical Industries Ltd. tumbled 8% in morning trade Monday on heavy volume, putting them on track to close at a 14-year low, as Morgan Stanley turned bearish on the generic drug maker i.....»»

Category: topSource: marketwatchAug 7th, 2017

Is a Surprise in the Cards for Teva (TEVA) in Q2 Earnings?

While the inclusion of sales from Actavis Generics acquisition may continue to pull up Teva Pharmaceutical Industries Ltd.'s (TEVA) sales, its generic segment may see weakness. .....»»

Category: worldSource: nytJul 31st, 2017

How approval of a low-price generic HIV prevention drug could hit Gilead

Foster City's Gilead Sciences won approval in 2012 of Truvada as the first drug to prevent the spread of the AIDS virus. What does it mean now that Teva Pharmaceutical Industries has won the OK to introduce a supposedly low-cost version of the drug?.....»»

Category: topSource: bizjournalsJun 9th, 2017

Teva"s Stock Inches Higher Amid Cost-Cutting Plan

Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA), the troubled Israel-based generic and specialty medicines developer, confirmed with Bloomberg a plan to lower expenses and better manage its debt. read more.....»»

Category: blogSource: benzingaMar 23rd, 2017

The world’s biggest generic drugs producer is cutting 6,000 jobs: report

Teva Pharmaceutical Industries Ltd. plans to cut as many as 6,000 jobs, or about 11 percent of its global workforce.....»»

Category: topSource: moneycentralMar 23rd, 2017

Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Mylan N.V. (MYL) Accused Of Price Fixing By 20 More States

The number of states accusing Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Mylan N.V. (NASDAQ:MYL) for price collusion have rise.....»»

Category: topSource: insidermonkeyMar 2nd, 2017

Manufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

Pfizer Inc. (NYSE:PFE) has been slapped with a warning letter by the Food and Drug Administration in regards to one of its fill/finish fac.....»»

Category: topSource: insidermonkeyFeb 22nd, 2017